BlackRock Investment Management’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

BlackRock Investment Management’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$46K	Sell	66,675 -6,680	-9%	-$7.96K	﹤0.01%	3315
2016 Q3	$104K	Buy	73,355 +10,800	+17%	+$16.7K	﹤0.01%	3276
2016 Q2	$102K	Hold	62,555	–	–	﹤0.01%	3308
2016 Q1	$133K	Sell	62,555 -25,800	-29%	-$71.2K	﹤0.01%	3214
2015 Q4	$343K	Sell	88,355 -4,000	-4%	-$15.2K	﹤0.01%	3128
2015 Q3	$318K	Buy	92,355 +2,962	+3%	+$12.6K	﹤0.01%	3161
2015 Q2	$442K	Buy	89,393 +3,709	+4%	+$16.4K	﹤0.01%	3157
2015 Q1	$421K	Buy	85,684 +8,047	+10%	+$37.2K	﹤0.01%	3029
2014 Q4	$322K	Sell	77,637 -1,165	-1%	-$5.29K	﹤0.01%	3171
2014 Q3	$453K	Buy	+78,802	New	+$475K	﹤0.01%	3028

Other funds holding PARN

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.76% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Investment Management's PARN Position: Q4 2016 in Review

BlackRock Investment Management reduced its Parnell Pharmaceuticals Holdings Ltd (PARN) stake by 9.1% in Q4 2016, selling an estimated $7.96K and leaving 66,675 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

BlackRock Investment Management first reported a position in PARN in Q3 2014 and has held it in 10 quarters since. The position peaked at $453K in Q3 2014. 20 funds tracked by Wall St. Rank hold PARN as of Q4 2016.

BlackRock Investment Management held 66,675 shares of Parnell Pharmaceuticals Holdings Ltd worth $46K as of Q4 2016.
BlackRock Investment Management sold 6,680 Parnell Pharmaceuticals Holdings Ltd shares in Q4 2016, an estimated $7.96K.
Parnell Pharmaceuticals Holdings Ltd made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3315 holding.
BlackRock Investment Management first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and has held it in 10 quarters since.
BlackRock Investment Management's Parnell Pharmaceuticals Holdings Ltd position peaked at $453K in Q3 2014.
20 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.